Congenital deficiency of fibrin-stabilizing factor (factor XIII). A report of the first case from Latin America.
Congenital deficiency of fibrin-stabilizing factor (factor XIII). A report of the first case from Latin America.
复制标题
先天性纤维蛋白稳定因子(因子 XIII)缺乏。
DOI:
10.1159/000208923
复制
发表时间:
1968
影响因子:
2.4
通讯作者:
J. R. Rangel
中科院分区:
文献类型:
--
作者:
T. Arends;J. M. Guevara;J. R. Rangel
MethodsThe coagulation tests were performed by the standard methods [15], and the plasma clot solubility in 5M urea was done according to LOSOWSKY et al.[8]. The defect of these patients being in the clot, it was thought that re-dissolving it with trypsin and studying it clcctrophoretically, a difference might be observed when compared with the normal subjects. The following method was used: 0.5 ml of oxalatcd plasma mixed with 0.5 ml of 0.025 M of CaCl2, incubated 30 min at 37 C; the clot was tapped loose and washed 3 times with NaCl 0.85% and then trypsin digested with a drop of commercial trypsin (NBCo) 4 mg/ml at 37 C for 2 h, shaking gently at intervals 2 or 3 times; trypsin digestion was stopped adjusting to pH 6.4 with 0.5 M acetic acid, and centrifugated at 2000 rpm. Acetate cellulose electro phoresis of the supernatant liquid was made applying the sample 6 times.